Filing Details
- Accession Number:
- 0001209191-17-016741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-02 16:56:09
- Reporting Period:
- 2017-02-28
- Filing Date:
- 2017-03-02
- Accepted Time:
- 2017-03-02 16:56:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1129890 | W Frederick Driscoll | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-28 | 30,000 | $7.89 | 41,211 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-28 | 32,834 | $19.96 | 8,377 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 600 | $20.42 | 7,777 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2017-02-28 | 30,000 | $0.00 | 30,000 | $7.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,300 | 2023-05-19 | No | 4 | M | Direct |
Footnotes
- Includes 680 shares of Common Stock that were acquired by the Reporting Person on November 20, 2015 pursuant to the Issuer's Employee Stock Purchase Plan.
- Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted December 20, 2016.
- The weighted average sale price for the transaction reported was $19.9619, and the range of prices were between $19.41 and $20.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $20.4167, and the range of prices were between $20.41 and $20.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- 1/4 of the shares subject to the option vest one year after May 20, 2013, with 1/48th of the shares vesting monthly thereafter over the next 3 years.
Billionaire Hedge Funds
